Classic models explain biased GPCR signaling through ligands that stabilize distinct receptor conformations and thereby favor selective transducer interactions. This remains a powerful framework, but the examples highlighted this week point to an additional route: intracellular modulators that bind at receptor–transducer interfaces, alongside experimental systems that place GPCR signaling in more physiological cellular contexts.